Status: Recruiting
HPC Offered for PRESERVE Expansion
Ossium recognizes that not all patients who could benefit from Ossium's HPC, Marrow can access the PRESERVE trial for logistical or eligibility reasons. The HOPE program is expanded access program to serve these patients by providing our bone marrow product
Participants needed: 10
Trial details
Age: 12-80Biological sex: AllType: ObservationalSponsor: Ossium Health, Inc.Updated: Aug 28, 2025Locations: 4Duration: 1 Year
Eligibility criteria
Not listed